| Homocysteine lowering with folic acid and B vitamins in vascular disease | New England Journal of Medicine | 2006 | 1.3K |
| Multi-ethnic genome-wide association study for atrial fibrillation | Nature Genetics | 2018 | 277 |
| Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update | Stroke | 2017 | 264 |
| Contrast-induced nephropathy and long-term adverse events: cause and effect? | Clinical Journal of the American Society of Nephrology: CJASN | 2009 | 195 |
| Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial | Stroke | 2009 | 187 |
| Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial | Circulation: Cardiovascular Interventions | 2015 | 185 |
| Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation | Nature Genetics | 2017 | 176 |
| Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter | Circulation | 2009 | 169 |
| Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration | Circulation | 2017 | 157 |
| Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function | Journal of the American College of Cardiology | 2002 | 154 |
| Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial | JACC: Cardiovascular Imaging | 2009 | 135 |
| The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions | Circulation | 2010 | 120 |
| Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis | Canadian Journal of Cardiology | 2017 | 103 |
| The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study | JACC: Cardiovascular Interventions | 2019 | 98 |
| Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study | Heart | 2009 | 88 |
| Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry | International Journal of Stroke | 2016 | 86 |
| Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing) | American Journal of Cardiology | 2008 | 84 |
| Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial | JAMA Neurology | 2019 | 79 |
| Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention | Journal of the American College of Cardiology | 2003 | 70 |
| Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial | European Stroke Journal | 2016 | 65 |
| Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review | Clinical Biochemistry | 2008 | 61 |
| International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction | Circulation | 2015 | 58 |
| Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions | American Journal of Cardiology | 2004 | 58 |
| Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease | Circulation: Cardiovascular Imaging | 2016 | 39 |
| Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial | Journal of Stroke and Cerebrovascular Diseases | 2018 | 37 |
